Brookview Healthcare Center
BROOKVIEW HEALTHCARE CENTER in DEFIANCE, OH — inspection on February 25, 2026.
Found 3 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
completed the day before.Review of Resident #79's Treatment Administration Record (TAR) for the
reviewed date of 04/28/25 revealed orders for treatment are obtained from or approved by the
non-compliance investigated under Complaint Numbers 2629125 and 1266301.
365447 02/25/2026
Brookview Healthcare Center 214 Harding Street Defiance, OH 43512
Review of the medication error rate revealed there were 28 opportunities for medication administration and three errors due to omission of medications resulting in a medication error rate of 10.7%.
Review of the facility policy titled Administering Medications, with a last reviewed date of 04/28/25 revealed medications must be administered in accordance with the orders, including any required time frames.This deficiency represents non-compliance investigated under Complaint Numbers 2629125 and 1266301.
365447 02/25/2026
Brookview Healthcare Center 214 Harding Street Defiance, OH 43512
Review of Resident #78's quarterly MDS assessment dated [DATE] revealed Resident #78 had intact cognition with a BIMS score of 13.
Furthermore, Resident #78 was dependent for all mobility and hygiene needs.
Review of Resident #78's care plan dated 02/24/26 revealed Resident #78 had impaired cognition as evidence by deficits in memory, judgement, and decision making with interventions that included to administer medications as ordered and to review medications and record possible causes of cognitive deficits.
Review of Resident #78's physician orders revealed an order for Rivastigmine Transdermal Patch 24 hour 4.6 mg/24 hour with instructions to apply one patch transdermally one time a day for dementia.
Change the patch daily and place the patch in different areas of the body; remove old patch before applying a new one.
Observation of incontinence care and a bed bath on 02/24/26 at 10:36 A.M. revealed Resident #78 had two Rivastigmine patches on his left shoulder/chest area.
Interview on 02/24/26 at 10:58 A.M. with Licensed Practical Nurse (LPN) #362 verified Resident #78 had two Rivastigmine patches on at the same time.
One patch was dated 02/24/26 and the other patch was dated 02/23/26. LPN #362 stated she had taken off a patch this morning when she applied the Rivastigmine patch and so Resident #78 must have had three patches on at the same time.
Review of the manufacturer's instructions for the Rivastigmine patches revealed the previous days patch must be removed prior to applying a new patch.
Review of the facility policy titled, Administering Medication, revised 04/28/25 revealed if a dosage was believed to be inappropriate or excessive for a resident, or a medication had been identified as having potential adverse consequences for the resident or was suspected of being associated with adverse consequences the person preparing or administering the medication shall contact the resident's attending physician or the facility's medical director to discuss the concern.
The policy also stated medications must be administered in accordance with the orders, including any required time frames.
This deficiency represents non-compliance investigated under Complaint Numbers 2629125 and 1266301.